Market News Archives

Serina Therapeutics: Optimizing Drug Delivery for the Future – ( $SER )

by John F. Heerdink, Jr. July 7, 2025 517Views 0Likes

Serina Therapeutics (NYSE: SER) is positioning itself at the forefront of a new era in drug development, as highlighted in a recent corporate video titled "Rethinking Drug Development: Faster, Smarter, Strategic and reinforced by a series of strategic moves and partnerships.…

From Bitcoin to Ethereum: BitMine’s Bold Treasury Move Draws Wall Street’s Attention ( $BMNR $BTC $ETH )

by John F. Heerdink, Jr. July 1, 2025 507Views 0Likes

BitMine Immersion Technologies (Nasdaq: BMNR), a Las Vegas-based cryptocurrency miner, has dramatically repositioned itself with a bold pivot toward Ethereum, igniting a spectacular surge in its stock price. On June 30, the company announced a $250 million private placement aimed at building…

Modular Medical (Nasdaq: MODD) Unveils Updated Investor Presentation, Emphasizing Disruptive Business Model and Near-Term Milestones

by John F. Heerdink, Jr. June 30, 2025 809Views 0Likes

Over the weekend, Modular Medical, Inc. (Nasdaq: MODD), a San Diego-based innovator in insulin delivery technology, quietly published an updated investor presentation , signaling a new phase in its campaign to transform diabetes care. The release comes on the heels of the…

Palantir and Holtec: A Data-Driven Power Couple Eyeing the Nuclear Renaissance – ( $PLTR $XLE )

by John F. Heerdink, Jr. June 26, 2025 593Views 0Likes

In a move that might make even Silicon Valley’s most seasoned disruptors do a double take, Palantir Technologies (PLTR) and Holtec International have announced a partnership that could reimagine the nuclear energy landscape. Their joint venture, called SMR-300, aims to supercharge the…

Eupraxia’s Strong Clinical Pipeline & Revenue Growth Potential Garnering Wall Street Attention

by John F. Heerdink, Jr. June 26, 2025 427Views 0Likes

Eupraxia Pharmaceuticals , a clinical-stage biotechnology firm headquartered in Victoria, Canada, has quietly become one of the more intriguing stories on both sides of the border in 2025. The company’s shares now trade under the ticker EPRX on both the Nasdaq and…

Rio Tinto and Hancock Prospecting: A Billion-Dollar Vote of Confidence in Pilbara’s Iron Ore Future – ( $RIO )

by John F. Heerdink, Jr. June 25, 2025 760Views 0Likes

What do you get when two mining titans decide to double down on one of the world’s richest iron ore regions? A $1.6 billion investment, a flurry of hard hats, and a renewed sense of optimism for Western Australia’s Pilbara, courtesy of…

GeoVax Secures Patent for Groundbreaking Malaria Vaccine Platform – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. June 25, 2025 638Views 0Likes

In a move that both underlines scientific ingenuity and bolsters global health ambitions, GeoVax Labs, Inc. (GOVX) has announced the issuance of U.S. Patent No. 12,329,808, a milestone that covers a novel vaccine construct designed to prevent malaria infection. This patent, granted…

GeoVax Applauds FDA’s Green Light for Keytruda: A New Chapter in Head and Neck Cancer—and a Wink at Gedeptin’s Future – ( $GOVX $MRK $XBI )

by John F. Heerdink, Jr. June 24, 2025 533Views 0Likes

In the ever-evolving world of oncology, every so often a regulatory decision comes along that feels less like a footnote and more like a new chapter. The U.S. Food and Drug Administration’s (FDA) recent approval of Merck’s (MRK) Keytruda® (pembrolizumab) for resectable,…

Modular Medical’s GLP-1 Pump Study: A Fresh Take on Diabetes & Obesity Management Innovation – ( $MODD $LLY $NVS )

by John F. Heerdink, Jr. June 23, 2025 691Views 0Likes

Modular Medical, Inc. (NASDAQ: MODD) , a company with a knack for shaking up the insulin delivery market, is set to make a splash at the American Diabetes Association (ADA) 85th Scientific Sessions taking place June 20-23, 2025, at the McCormick…

GeoVax Labs: A Shot in the Arm for Global Health, with a European Twist – ( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. June 18, 2025 538Views 0Likes

In a world where vaccine innovation can sometimes feel like a slow-motion sprint, GeoVax Labs, Inc. (NASDAQ: GOVX) has just received a welcome boost—this time, courtesy of European regulators. The company, known for its nimble approach to tackling some of the world’s…

Market News

Your Guide To Staying Informed In The Markets